Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
3.850
+0.280 (7.84%)
At close: Nov 20, 2024, 4:00 PM
3.640
-0.210 (-5.45%)
After-hours: Nov 20, 2024, 7:21 PM EST
Biodexa Pharmaceuticals Employees
Biodexa Pharmaceuticals had 21 employees as of December 31, 2023. The number of employees decreased by 6 or -22.22% compared to the previous year.
Employees
21
Change (1Y)
-6
Growth (1Y)
-22.22%
Revenue / Employee
$4,995
Profits / Employee
-$410,371
Market Cap
2.24M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Venus Concept | 304 |
| Xylo Technologies | 84 |
| Scorpius Holdings | 84 |
| HeartSciences | 15 |
| Phio Pharmaceuticals | 9 |
| PainReform | 7 |
| 180 Life Sciences | 4 |
| Qualigen Therapeutics | 4 |
BDRX News
- 8 days ago - Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Regains Compliance For Continued Listing on Nasdaq - GlobeNewsWire
- 13 days ago - Notice of General Meeting - GlobeNewsWire
- 20 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Biodexa Pharmaceuticals Plc (BDRX) And Encourages Shareholders to Reach Out - Accesswire
- 21 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biodexa Pharmaceuticals Plc (BDRX) and Encourages Investors to Learn More About the Investigation - Accesswire
- 22 days ago - Biodexa Pharmaceuticals Plc (BDRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 23 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Biodexa Pharmaceuticals Plc (BDRX) And Encourages Stockholders to Reach Out - Accesswire
- 24 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Biodexa Pharmaceuticals Plc (BDRX) And Encourages Stockholders to Connect - Accesswire
- 5 weeks ago - Biodexa's MX-110 Continues to Show Promise in Recurrent Glioblastoma (rGBM), the Deadliest Brain Cancer - Accesswire